Cogent Biosciences Stock Price on December 24, 2024
| COGT Stock | USD 7.83 0.03 0.38% |
Below is the normalized historical share price chart for Cogent Biosciences extending back to March 29, 2018. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Cogent Biosciences stands at 7.83, as last reported on the 26th of December, with the highest price reaching 7.88 and the lowest price hitting 7.62 during the day.
If you're considering investing in Cogent Stock, it is important to understand the factors that can impact its price. Cogent Biosciences secures Sharpe Ratio (or Efficiency) of -0.12, which signifies that the company had a -0.12% return per unit of risk over the last 3 months. Cogent Biosciences exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Cogent Biosciences' Mean Deviation of 2.29, risk adjusted performance of (0.08), and Standard Deviation of 3.56 to double-check the risk estimate we provide.
At this time, Cogent Biosciences' Common Stock Shares Outstanding is comparatively stable compared to the past year. Common Stock Total Equity is likely to gain to about 84.5 K in 2024, whereas Capital Stock is likely to drop slightly above 59.1 M in 2024. . Price To Sales Ratio is likely to drop to 12.32 in 2024. Price Earnings Ratio is likely to drop to -2.56 in 2024. Cogent Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 29th of March 2018 | 200 Day MA 8.9552 | 50 Day MA 10.0201 | Beta 0.021 |
Cogent |
Sharpe Ratio = -0.1249
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | COGT |
Estimated Market Risk
| 3.6 actual daily | 32 68% of assets are more volatile |
Expected Return
| -0.45 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.12 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Cogent Biosciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cogent Biosciences by adding Cogent Biosciences to a well-diversified portfolio.
Price Book 4.2548 | Enterprise Value Ebitda (3.89) | Price Sales 1.3 K | Shares Float 70.9 M | Wall Street Target Price 16.8 |
Related Headline
Kura Oncology Headline on 24th of December 2024
Kura Oncologys Stock Sinks To US8.94, But Insiders Sold Even... by simplywall.st
Even though Kura Oncology, Inc. has fallen by 10 percent over the past week , insiders who sold US240k worth...
Cogent Biosciences Valuation on December 24, 2024
It is possible to determine the worth of Cogent Biosciences on a given historical date. On December 24, 2024 Cogent was worth 7.75 at the beginning of the trading date compared to the closed value of 7.86. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Cogent Biosciences stock. Still, in general, we apply an absolute valuation method to find Cogent Biosciences' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Cogent Biosciences where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Cogent Biosciences' related companies.
| Open | High | Low | Close | Volume | |
| 7.81 | 7.93 | 7.42 | 7.76 | 1,293,514 | |
12/24/2024 | 7.75 | 7.88 | 7.62 | 7.86 | 537,249 |
| 7.86 | 7.88 | 7.62 | 7.83 | 0.00 |
| Backtest Cogent Biosciences | | | Cogent Biosciences History | | | Cogent Biosciences Valuation | Previous | Next |
Cogent Biosciences Trading Date Momentum on December 24, 2024
| On December 26 2024 Cogent Biosciences was traded for 7.83 at the closing time. The top price for the day was 7.88 and the lowest listed price was 7.62 . There was no trading activity during the period 0.0. Lack of trading volume on December 26, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 0.38% . The overall trading delta against the current closing price is 0.00% . |
Cogent Biosciences Fundamentals Correlations and Trends
By evaluating Cogent Biosciences' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Cogent Biosciences' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Cogent financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Cogent Biosciences Stock history
Cogent Biosciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cogent is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cogent Biosciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cogent Biosciences stock prices may prove useful in developing a viable investing in Cogent Biosciences
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 79.7 M | 83.6 M | |
| Net Loss | -126.2 M | -132.5 M |
Cogent Biosciences Quarterly Net Working Capital |
|
Cogent Biosciences Stock Technical Analysis
Cogent Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Cogent Biosciences Period Price Range
Low | December 26, 2024
| High |
0.00 | 0.00 |
Cogent Biosciences cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Cogent Biosciences December 26, 2024 Market Strength
Market strength indicators help investors to evaluate how Cogent Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cogent Biosciences shares will generate the highest return on investment. By undertsting and applying Cogent Biosciences stock market strength indicators, traders can identify Cogent Biosciences entry and exit signals to maximize returns
Cogent Biosciences Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Cogent Biosciences' price direction in advance. Along with the technical and fundamental analysis of Cogent Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cogent to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.08) | |||
| Jensen Alpha | (0.45) | |||
| Total Risk Alpha | (0.56) | |||
| Treynor Ratio | (0.33) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Cogent Stock Analysis
When running Cogent Biosciences' price analysis, check to measure Cogent Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cogent Biosciences is operating at the current time. Most of Cogent Biosciences' value examination focuses on studying past and present price action to predict the probability of Cogent Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cogent Biosciences' price. Additionally, you may evaluate how the addition of Cogent Biosciences to your portfolios can decrease your overall portfolio volatility.